Which has stronger earnings & valuation, AFYA or LAUR?

Laureate Education has higher revenue and earnings than Afya. Afya is trading at a lower price-to-earnings ratio than Laureate Education, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Afya $662.01M 1.97 $134.77M $1.64 8.47 Laureate Education $1.70B 2.92 $281.63M $2.23 16.20

Is AFYA or LAUR more profitable?

Afya has a net margin of 20.55% compared to Laureate Education's net margin of 17.57%. Laureate Education's return on equity of 23.54% beat Afya's return on equity. Company Net Margins Return on Equity Return on Assets Afya 20.55% 17.58% 9.09% Laureate Education 17.57% 23.54% 11.72%

Do analysts prefer AFYA or GHC?

Afya presently has a consensus target price of $18.00, suggesting a potential upside of 29.59%. Given Afya's higher possible upside, analysts plainly believe Afya is more favorable than Graham. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Afya 1 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.83 Graham 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has better earnings and valuation, AFYA or GHC?

Graham has higher revenue and earnings than Afya. Afya is trading at a lower price-to-earnings ratio than Graham, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Afya $662.01M 1.97 $134.77M $1.64 8.47 Graham $5.07B 0.95 $292.29M $124.08 9.16

Is AFYA or GHC more profitable?

Afya has a net margin of 20.55% compared to Graham's net margin of 10.69%. Afya's return on equity of 17.58% beat Graham's return on equity. Company Net Margins Return on Equity Return on Assets Afya 20.55% 17.58% 9.09% Graham 10.69% 5.73% 3.32%

Which has preferable earnings and valuation, CVSA or AFYA?

Adtalem Global Education has higher revenue and earnings than Afya. Afya is trading at a lower price-to-earnings ratio than Adtalem Global Education, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Adtalem Global Education $1.95B 2.18 $251.57M $7.04 17.82 Afya $662.01M 1.97 $134.77M $1.64 8.47

Which has better valuation & earnings, AFYA or LOPE?

Grand Canyon Education has higher revenue and earnings than Afya. Afya is trading at a lower price-to-earnings ratio than Grand Canyon Education, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Afya $662.01M 1.97 $134.77M $1.64 8.47 Grand Canyon Education $1.11B 3.56 $216.17M $8.27 18.28

Do analysts recommend LRN or AFYA?

Stride presently has a consensus price target of $95.75, indicating a potential upside of 16.70%. Afya has a consensus price target of $18.00, indicating a potential upside of 29.59%. Given Afya's higher probable upside, analysts plainly believe Afya is more favorable than Stride. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stride 0 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.43 Afya 1 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.83

Which has stronger earnings and valuation, LRN or AFYA?

Stride has higher revenue and earnings than Afya. Afya is trading at a lower price-to-earnings ratio than Stride, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Stride $2.52B 1.35 $338.19M $7.20 11.40 Afya $662.01M 1.97 $134.77M $1.64 8.47

Is LRN or AFYA more profitable?

Afya has a net margin of 20.55% compared to Stride's net margin of 13.43%. Stride's return on equity of 23.49% beat Afya's return on equity. Company Net Margins Return on Equity Return on Assets Stride 13.43% 23.49% 15.66% Afya 20.55% 17.58% 9.09%

Afya (AFYA) Competitors

$13.89 +0.32 (+2.36%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$13.86 -0.03 (-0.18%)

As of 09/11/2026 07:30 PM Eastern

Compare

AFYA vs. LAUR, GHC, CVSA, LOPE, and LRN

Should you buy Afya stock or one of its competitors? Afya's main competitors and comparable companies include Laureate Education (LAUR), Graham (GHC), Adtalem Global Education (CVSA), Grand Canyon Education (LOPE), and Stride (LRN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "education services" industry.

How does Afya compare to Laureate Education?

Afya (NASDAQ:AFYA) and Laureate Education (NASDAQ:LAUR) are both consumer discretionary companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

88.0% of Afya shares are held by institutional investors. Comparatively, 96.3% of Laureate Education shares are held by institutional investors. 0.8% of Afya shares are held by insiders. Comparatively, 1.5% of Laureate Education shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Afya has a net margin of 20.55% compared to Laureate Education's net margin of 17.57%. Laureate Education's return on equity of 23.54% beat Afya's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Afya	20.55%	17.58%	9.09%
Laureate Education	17.57%	23.54%	11.72%

Afya currently has a consensus target price of $18.00, indicating a potential upside of 29.59%. Laureate Education has a consensus target price of $40.50, indicating a potential upside of 12.10%. Given Afya's higher possible upside, research analysts plainly believe Afya is more favorable than Laureate Education.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Afya	1 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.83
Laureate Education	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.57

In the previous week, Laureate Education had 2 more articles in the media than Afya. MarketBeat recorded 3 mentions for Laureate Education and 1 mentions for Afya. Laureate Education's average media sentiment score of 1.17 beat Afya's score of 0.62 indicating that Laureate Education is being referred to more favorably in the news media.

Company	Overall Sentiment
Afya	Positive
Laureate Education	Positive

Afya has a beta of 0.35, meaning that its stock price is 65% less volatile than the broader market. Comparatively, Laureate Education has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market.

Laureate Education has higher revenue and earnings than Afya. Afya is trading at a lower price-to-earnings ratio than Laureate Education, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Afya	$662.01M	1.97	$134.77M	$1.64	8.47
Laureate Education	$1.70B	2.92	$281.63M	$2.23	16.20

Summary

Laureate Education beats Afya on 15 of the 17 factors compared between the two stocks.

How does Afya compare to Graham?

Afya (NASDAQ:AFYA) and Graham (NYSE:GHC) are both consumer discretionary companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, dividends, risk, valuation, earnings and institutional ownership.

Graham has higher revenue and earnings than Afya. Afya is trading at a lower price-to-earnings ratio than Graham, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Afya	$662.01M	1.97	$134.77M	$1.64	8.47
Graham	$5.07B	0.95	$292.29M	$124.08	9.16

Afya pays an annual dividend of $0.66 per share and has a dividend yield of 4.8%. Graham pays an annual dividend of $7.52 per share and has a dividend yield of 0.7%. Afya pays out 40.2% of its earnings in the form of a dividend. Graham pays out 6.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Graham has raised its dividend for 10 consecutive years.

88.0% of Afya shares are held by institutional investors. Comparatively, 93.2% of Graham shares are held by institutional investors. 0.8% of Afya shares are held by insiders. Comparatively, 18.6% of Graham shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Afya has a net margin of 20.55% compared to Graham's net margin of 10.69%. Afya's return on equity of 17.58% beat Graham's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Afya	20.55%	17.58%	9.09%
Graham	10.69%	5.73%	3.32%

In the previous week, Graham had 3 more articles in the media than Afya. MarketBeat recorded 4 mentions for Graham and 1 mentions for Afya. Graham's average media sentiment score of 0.92 beat Afya's score of 0.62 indicating that Graham is being referred to more favorably in the news media.

Company	Overall Sentiment
Afya	Positive
Graham	Positive

Afya has a beta of 0.35, meaning that its share price is 65% less volatile than the broader market. Comparatively, Graham has a beta of 0.71, meaning that its share price is 29% less volatile than the broader market.

Afya presently has a consensus target price of $18.00, suggesting a potential upside of 29.59%. Given Afya's higher possible upside, analysts plainly believe Afya is more favorable than Graham.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Afya	1 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.83
Graham	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Graham beats Afya on 13 of the 19 factors compared between the two stocks.

How does Afya compare to Adtalem Global Education?

Adtalem Global Education (NYSE:CVSA) and Afya (NASDAQ:AFYA) are both consumer discretionary companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation.

Adtalem Global Education presently has a consensus price target of $155.00, indicating a potential upside of 23.58%. Afya has a consensus price target of $18.00, indicating a potential upside of 29.59%. Given Afya's higher possible upside, analysts clearly believe Afya is more favorable than Adtalem Global Education.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adtalem Global Education	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
Afya	1 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.83

Adtalem Global Education has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market. Comparatively, Afya has a beta of 0.35, meaning that its share price is 65% less volatile than the broader market.

In the previous week, Adtalem Global Education and Adtalem Global Education both had 1 articles in the media. Afya's average media sentiment score of 0.62 beat Adtalem Global Education's score of 0.11 indicating that Afya is being referred to more favorably in the news media.

Company	Overall Sentiment
Adtalem Global Education	Neutral
Afya	Positive

Adtalem Global Education has higher revenue and earnings than Afya. Afya is trading at a lower price-to-earnings ratio than Adtalem Global Education, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adtalem Global Education	$1.95B	2.18	$251.57M	$7.04	17.82
Afya	$662.01M	1.97	$134.77M	$1.64	8.47

98.8% of Adtalem Global Education shares are held by institutional investors. Comparatively, 88.0% of Afya shares are held by institutional investors. 2.5% of Adtalem Global Education shares are held by insiders. Comparatively, 0.8% of Afya shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Afya has a net margin of 20.55% compared to Adtalem Global Education's net margin of 12.87%. Adtalem Global Education's return on equity of 20.88% beat Afya's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adtalem Global Education	12.87%	20.88%	10.49%
Afya	20.55%	17.58%	9.09%

Summary

Adtalem Global Education beats Afya on 12 of the 15 factors compared between the two stocks.

How does Afya compare to Grand Canyon Education?

Afya (NASDAQ:AFYA) and Grand Canyon Education (NASDAQ:LOPE) are both consumer discretionary companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk.

Grand Canyon Education has higher revenue and earnings than Afya. Afya is trading at a lower price-to-earnings ratio than Grand Canyon Education, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Afya	$662.01M	1.97	$134.77M	$1.64	8.47
Grand Canyon Education	$1.11B	3.56	$216.17M	$8.27	18.28

Afya presently has a consensus price target of $18.00, indicating a potential upside of 29.59%. Grand Canyon Education has a consensus price target of $161.67, indicating a potential upside of 6.92%. Given Afya's higher probable upside, equities research analysts clearly believe Afya is more favorable than Grand Canyon Education.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Afya	1 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.83
Grand Canyon Education	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

Afya has a net margin of 20.55% compared to Grand Canyon Education's net margin of 19.63%. Grand Canyon Education's return on equity of 36.62% beat Afya's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Afya	20.55%	17.58%	9.09%
Grand Canyon Education	19.63%	36.62%	26.87%

88.0% of Afya shares are owned by institutional investors. Comparatively, 94.2% of Grand Canyon Education shares are owned by institutional investors. 0.8% of Afya shares are owned by insiders. Comparatively, 2.1% of Grand Canyon Education shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Grand Canyon Education had 6 more articles in the media than Afya. MarketBeat recorded 7 mentions for Grand Canyon Education and 1 mentions for Afya. Grand Canyon Education's average media sentiment score of 1.74 beat Afya's score of 0.62 indicating that Grand Canyon Education is being referred to more favorably in the news media.

Company	Overall Sentiment
Afya	Positive
Grand Canyon Education	Very Positive

Afya has a beta of 0.35, suggesting that its share price is 65% less volatile than the broader market. Comparatively, Grand Canyon Education has a beta of 0.58, suggesting that its share price is 42% less volatile than the broader market.

Summary

Grand Canyon Education beats Afya on 14 of the 16 factors compared between the two stocks.

How does Afya compare to Stride?

Stride (NYSE:LRN) and Afya (NASDAQ:AFYA) are both consumer discretionary companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation.

Afya has a net margin of 20.55% compared to Stride's net margin of 13.43%. Stride's return on equity of 23.49% beat Afya's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stride	13.43%	23.49%	15.66%
Afya	20.55%	17.58%	9.09%

In the previous week, Stride had 5 more articles in the media than Afya. MarketBeat recorded 6 mentions for Stride and 1 mentions for Afya. Stride's average media sentiment score of 0.98 beat Afya's score of 0.62 indicating that Stride is being referred to more favorably in the media.

Company	Overall Sentiment
Stride	Positive
Afya	Positive

Stride has higher revenue and earnings than Afya. Afya is trading at a lower price-to-earnings ratio than Stride, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stride	$2.52B	1.35	$338.19M	$7.20	11.40
Afya	$662.01M	1.97	$134.77M	$1.64	8.47

Stride presently has a consensus price target of $95.75, indicating a potential upside of 16.70%. Afya has a consensus price target of $18.00, indicating a potential upside of 29.59%. Given Afya's higher probable upside, analysts plainly believe Afya is more favorable than Stride.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stride	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43
Afya	1 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.83

Stride has a beta of 0.11, indicating that its stock price is 89% less volatile than the broader market. Comparatively, Afya has a beta of 0.35, indicating that its stock price is 65% less volatile than the broader market.

98.2% of Stride shares are owned by institutional investors. Comparatively, 88.0% of Afya shares are owned by institutional investors. 3.0% of Stride shares are owned by insiders. Comparatively, 0.8% of Afya shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Stride beats Afya on 12 of the 16 factors compared between the two stocks.

Get Afya News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AFYA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AFYA vs. The Competition

Export

Metric	Afya	Diversified Consumer Services Industry	Consumer Discretionary Sector	NASDAQ Exchange
Market Cap	$1.30B	$4.28B	$12.71B	$12.85B
Dividend Yield	4.72%	2.88%	56.80%	11.17%
P/E Ratio	8.47	9.94	45.78	25.36
Price / Sales	1.97	35.70	93.79	116.83
Price / Cash	5.77	13.69	28.56	51.52
Price / Book	1.49	3.11	4.08	6.20
Net Income	$134.77M	$241.15M	$445.67M	$358.50M
7 Day Performance	-5.38%	-1.95%	-2.31%	-2.35%
1 Month Performance	3.58%	-3.57%	-4.15%	-3.23%
1 Year Performance	-10.96%	-6.67%	-6.10%	8.79%

Afya Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AFYA Afya	4.1388 of 5 stars	$13.89 +2.4%	$18.00 +29.6%	-11.0%	$1.30B	$662.01M	8.47	9,395	High Trading Volume
LAUR Laureate Education	3.6283 of 5 stars	$36.66 -0.3%	$40.50 +10.5%	+22.9%	$5.05B	$1.70B	16.43	33,900	Analyst Upgrade Gap Down
GHC Graham	2.1721 of 5 stars	$1,127.99 -0.7%	N/A	-3.0%	$4.77B	$4.91B	9.09	19,920	News Coverage Dividend Announcement Analyst Downgrade
CVSA Adtalem Global Education	3.9156 of 5 stars	$126.28 -1.4%	$155.00 +22.7%	N/A	$4.31B	$1.95B	18.00	10,680
LOPE Grand Canyon Education	2.8253 of 5 stars	$152.36 -0.2%	$161.67 +6.1%	-27.9%	$3.97B	$1.11B	18.42	5,830	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AFYA) was last updated on 9/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Afya (AFYA) Competitors

AFYA vs. LAUR, GHC, CVSA, LOPE, and LRN

How does Afya compare to Laureate Education?

Summary

How does Afya compare to Graham?

Summary

How does Afya compare to Adtalem Global Education?

Summary

How does Afya compare to Grand Canyon Education?

Summary

How does Afya compare to Stride?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AFYA vs. The Competition

Afya Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Afya (AFYA) Competitors

AFYA vs. LAUR, GHC, CVSA, LOPE, and LRN

How does Afya compare to Laureate Education?

Do institutionals & insiders hold more shares of AFYA or LAUR?

Is AFYA or LAUR more profitable?

Do analysts rate AFYA or LAUR?

Does the media refer more to AFYA or LAUR?

Which has more risk & volatility, AFYA or LAUR?

Which has stronger earnings & valuation, AFYA or LAUR?

Summary

How does Afya compare to Graham?

Which has better earnings and valuation, AFYA or GHC?

Is AFYA or GHC a better dividend stock?

Do insiders and institutionals hold more shares of AFYA or GHC?

Is AFYA or GHC more profitable?

Does the media favor AFYA or GHC?

Which has more risk & volatility, AFYA or GHC?

Do analysts prefer AFYA or GHC?

Summary

How does Afya compare to Adtalem Global Education?

Do analysts rate CVSA or AFYA?

Which has more risk and volatility, CVSA or AFYA?

Does the media favor CVSA or AFYA?

Which has preferable earnings and valuation, CVSA or AFYA?

Do insiders & institutionals believe in CVSA or AFYA?

Is CVSA or AFYA more profitable?

Summary

How does Afya compare to Grand Canyon Education?

Which has better valuation & earnings, AFYA or LOPE?

Do analysts recommend AFYA or LOPE?

Is AFYA or LOPE more profitable?

Do insiders and institutionals believe in AFYA or LOPE?

Does the media refer more to AFYA or LOPE?

Which has more volatility & risk, AFYA or LOPE?

Summary

How does Afya compare to Stride?

Is LRN or AFYA more profitable?

Does the media favor LRN or AFYA?

Which has stronger earnings and valuation, LRN or AFYA?

Do analysts recommend LRN or AFYA?

Which has more volatility and risk, LRN or AFYA?

Do insiders & institutionals believe in LRN or AFYA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AFYA vs. The Competition

Afya Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools